Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs KLA Corp. (KLAC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs KLA Corp. — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.14 (market cap $4.02B), while KLA Corp. trades at $174.53 (market cap $233.35B). The key difference: KLA Corp. is far larger — about 58× Edgewise Therapeutics Inc. Common Stock's market cap, and KLA Corp. pays a 0.51% dividend while Edgewise Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and KLA Corp. for 60 Days on average.
| EWTX | KLAC | |
|---|---|---|
Market Cap | $4.02B | $233.35B |
Volume | 1,446,128 | 14,457,699 |
Sector | Health | Technology |
52-Week High | $48.35 | $301.71 |
52-Week Low | $14.89 | $108.70 |
Typical Hold Time | 0 Days | 60 Days |
Enterprise Value | $3.56B | $234.60B |
Dividend Yield | — | 0.51% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
KLA Corporation (KLAC) trades at $184.00, down 3.22% on the day, with strong fundamental performance including 35.57% net income margin and 87.5% ROE. The stock shows bullish technical signals with recent earnings beats and a $12.57 billion backlog driven by AI demand. Revenue grew to $12.16 billion in 2025, with analysts projecting $13.6 billion for 2026.
Outlook remains positive with 63.6% analyst buy ratings and $223.88 consensus price target, representing 22% upside. Key risks include competitive pressures from AMAT and ASML, margin compression, and cyclical semiconductor equipment spending. The company's dominant position in semiconductor inspection equipment supports long-term growth prospects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About KLA Corp.
KLA designs and manufactures yield-management and process-monitoring diagnostic and control systems for the semiconductor manufacturing industry. The systems are used to analyze the manufacturing process at various steps in a semiconductor's development. The firm's laser-scanning products are used for wafer qualification, process monitoring, and equipment monitoring. KLA also provides inspection tools and systems for optical metrology and e-beam metrology.
Read more on KLAC →
